Research progress on the role of IgG N-glycosylation modification in diabetic retinopathy

doi:10.16352/j.issn.1001-6325.2023.03.509

Basic & Clinical Medicine ›› 2023, Vol. 43 ›› Issue (3): 509-513.doi: 10.16352/j.issn.1001-6325.2023.03.509

• Mini Reviews • Previous Articles Next Articles

Research progress on the role of IgG N-glycosylation modification in diabetic retinopathy

ZHANG Yixin¹, CAI Shanjun^1*, LI Zhili², YU Weihong³, ZHANG Hua^4*

1. Department of Ophthalmology, Affiliated Hospital of Zunyi Medical University, Zunyi 563003;
2. Department of Biophysics and Structural Biology, Institute of Basic Medical Sciences CAMS, School of Basic Medicine PUMC, Beijing 100005;
3. Department of Ophthalmology, Peking Union Medical College Hospital;
4. College of Continuing Education, CAMS ＆ PUMC, Beijing 100730, China

Received:2022-04-02 Revised:2022-10-17 Online:2023-03-05 Published:2023-02-27
Contact: * zhanghua.eye@163.com;caishanjun@163.com

Abstract

CLC Number:

R774.1

ZHANG Yixin, CAI Shanjun, LI Zhili, YU Weihong, ZHANG Hua. Research progress on the role of IgG N-glycosylation modification in diabetic retinopathy[J]. Basic & Clinical Medicine, 2023, 43(3): 509-513.

References

[1]Lechner J, Medina RJ, Lois N, et al. Advances in cell therapies using stem cells/progenitors as a novel approach for neurovascular repair of the diabetic retina[J]. Stem Cell Res Ther, 2022,13:388. doi:10.1186/s13287-022-03073-x.
[2]Štambuk J, Nakić N, Vučković F, et al. Global varia-bility of the human IgG glycome[J]. Aging (Albany NY), 2020,12:15222-15259.
[3]Singh SS, Heijmans R, Meulen C, et al. Association of the IgG N-glycome with the course of kidney function in type 2 diabetes[J]. BMJ Open Diabetes Res Care, 2020,8. doi:10.1136/bmjdrc-2019-001026.
[4]Giblin MJ, Ontko CD, Penn JS. Effect of cytokine-induced alterations in extracellular matrix composition on diabetic retinopathy-relevant endothelial cell behaviors[J]. Sci Rep, 2022,12:12955. doi:10.1038/s41598-022-12683-7.
[5]Lessieur EM, Liu H, Saadane A, et al. Neutrophil-derived proteases contribute to the pathogenesis of early diabetic retinopathy[J]. Invest Ophthalmol Vis Sci, 2021,62:7. doi:10.1167/iovs.62.13.7.
[6]Canataroglu H, Varinli I, Ozcan AA, et al. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composi-tion of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy[J]. Ocul Immunol Inflamm, 2005,13:375-381.
[7]Yu H, Liu B, Wu G, et al. Dysregulation of circulating follicular helper T cells in type 2 diabetic patients with diabetic retinopathy[J]. Immunol Res, 2021,69:153-161.
[8]Wu Z, Pan H, Liu D, et al. Variation of IgG N-linked glycosylation profile in diabetic retinopathy[J]. J Diabetes, 2021,13:672-680.
[9]孙扬, 李琪欢, 田思佳, 等. 免疫球蛋白GN-糖基化与糖尿病视网膜病变的相关性研究[J]. 中国预防医学杂志, 2018,19:734-737.
[10]Adua E, Memarian E, Afrifa-Yamoah E, et al. N-glycosylation profiling of type 2 diabetes mellitus from baseline to follow-up: an observational study in a Ghanaian population[J]. Biomark Med, 2021,15:467-480.
[11]Wada R, Matsui M, Kawasaki N. Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms[J]. MAbs, 2019,11:350-372.
[12]Aoyama M, Hashii N, Tsukimura W, et al. Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies[J]. MAbs, 2019,11:826-836.
[13]Clauder AK, Kordowski A, Bartsch YC, et al. IgG Fc N-glycosylation translates MHCII haplotype into autoimmune skin disease[J]. J Invest Dermatol, 2021,141:285-294.
[14]Lu J, Chu J, Zou Z, et al. Structure of FcγRI in complex with Fc reveals the importance of glycan recognition for high-affinity IgG binding[J]. Proc Natl Acad Sci U S A, 2015,112:833-838.
[15]Bournazos S, Vo H, Duong V, et al. Antibody fucosyla-tion predicts disease severity in secondary dengue infection[J]. Science, 2021,372:1102-1105.
[16]Ząbczyńska M, Polak K, Kozłowska K, et al. The contribution of IgG glycosylation to antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) in Hashimoto's thyroiditis: an in vitro model of thyroid autoimmunity[J]. Biomolecules, 2020,10. doi:10.3390/biom10020171.
[17]Ohmi Y, Ise W, Harazono A, et al. Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis[J]. Nat Commun, 2016,7:11205. doi:10.1038/ncomms11205.
[18]Quevedo-Martínez JU, Garfias Y, Jimenez J, et al. Pro-inflammatory cytokine profile is present in the serum of Mexican patients with different stages of diabetic retinopathy secondary to type 2 diabetes[J]. BMJ Open Ophthalmol, 2021,6:e000717. doi:10.1136/bmjophth-2021-000717.
[19]Bartsch YC, Eschweiler S, Leliavski A, et al. IgG Fc sialylation is regulated during the germinal center reaction following immunization with different adjuvants[J]. J Allergy Clin Immunol, 2020,146:652-666.e11.
[20]Dotz V, Lemmers R, Reiding KR, et al. Plasma protein N-glycan signatures of type 2 diabetes[J]. Biochim Biophys Acta Gen Subj, 2018,1862:2613-2622.
[21]Mahajan A, Taliun D, Thurner M, et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps[J]. Nat Genet, 2018,50:1505-1513.
[22]Irvine EB, Alter G. Understanding the role of antibody glycosylation through the lens of severe viral and bacterial diseases[J]. Glycobiology, 2020,30:241-253.
[23]Nakano M, Mishra SK, Tokoro Y, et al. Bisecting GlcNAc is a general suppressor of terminal modification of N-glycan[J]. Mol Cell Proteomics, 2019,18:2044-2057.
[24]Rudman N, Kifer D, Kaur S, et al. Children at onset of type 1 diabetes show altered N-glycosylation of plasma proteins and IgG[J]. Diabetologia, 2022. doi:10.1007/s00125-022-05703-8.
[25]杜钰莹, 王悦, 赖治臻, 等. 肺癌与肺良性疾病特异血清免疫炎性蛋白质N-糖基化修饰差异[J]. 基础医学与临床, 2020,40:1096-1102.

Research progress on the role of IgG N-glycosylation modification in diabetic retinopathy

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 5

Recommended Articles

Metrics

Comments

[1]	ZHOU Yue, LIN Jingna. miR-199-3p inhibits diabetes retinopathy in rats by targeting at VegfA [J]. Basic & Clinical Medicine, 2023, 43(7): 1084-1089.
[2]	LI Xiaona, QI Xianmei, ZHANG Tiantian, WANG Jing. Silencing Fcgr3 decreases SiO₂-induced inflammatory cytokines expression in mouse alveolar macrophage cell line MH-S [J]. Basic & Clinical Medicine, 2023, 43(6): 904-908.
[3]	ZHANG Mengyao, NIU Shu, CAI Jing, ZHAO Zhigang, ZHOU Yan. Effect of miR-140-5p targeting HMGB1/IκB-α axis on retinopathy of diabetic rats [J]. Basic & Clinical Medicine, 2023, 43(4): 615-620.
[4]	WANG Hui, SU Xian, ZHANG Yingying, CHU Zhanya, SUN Zhaohui, ZHANG Jinling, ZHANG Qianqian. Isoramin attenuates retinal cell apoptosis in diabetes retinopathy rats [J]. Basic & Clinical Medicine, 2023, 43(2): 265-270.
[5]	SUN Jian-ru, QIU Wen-ying, QIAN Xiao-jing, MA Chao. Expression of Fc-gamma receptor type Ⅰ in brain cortex of patients with Alzheimer's disease and the mouse model [J]. Basic & Clinical Medicine, 2022, 42(5): 740-744.